ELYRIS LABS

ELYRIS LABS

Elyris Labs

Engineering the Future of Cancer Drug Discovery

Engineering the Future of Cancer Drug Discovery

3D tumor simulation engine that thinks like biology, runs like software.

De-risk your pipeline. Explain why drugs win or fail. Screen at massive scale — instantly.

Oncology, re-engineered.

3D tumor simulation engine that thinks like biology, runs like software. De-risk your pipeline. Explain why drugs win or fail. Screen at massive scale — instantly. Oncology, re-engineered.

3D tumor simulation engine that thinks like biology, runs like software.

De-risk your pipeline. Explain why drugs win or fail. Screen at massive scale — instantly. Oncology, re-engineered.

Raising $2M Pre-Seed

Schedule Intro Call

Schedule Intro Call

Contact Us

Contact Us

//01 The Platform

//01 The Platform

Introducing LURA

GPU-accelerated 3D tumor microenvironment simulation — millions of parallel causal experiments in hours, not decades. We finally let the scientific method win in drug discovery: test vastly more hypotheses, measure real biological mechanism, and explain exactly why drugs succeed or fail — before anyone ever touches a pipette.

GPU-accelerated 3D tumor microenvironment simulation — millions of parallel causal experiments in hours, not decades.

We finally let the scientific method win in drug discovery: test vastly more hypotheses, measure real biological mechanism, and explain exactly why drugs succeed or fail — before anyone ever touches a pipette.

The Computational Barrier in Oncology

$2.6B + 12+ years per drug. Most oncology candidates still fail. Why? Tools give probabilities — not why a drug works in one context but fails in another.

Elyris Labs Ends the Guesswork

LURA delivers causal mechanistic insight into real tumor biology — explaining why compounds succeed or fail. Stop wasting experiments. Start advancing drugs that actually work.


Proudly accepted into the NVIDIA Inception Program.

This validates LURA — our GPU-accelerated 3D tumor simulation engine — and unlocks NVIDIA’s top-tier GPU resources, technical support, and co-marketing. We’re already running millions of parallel causal experiments in hours on A100s. With Inception, we’re accelerating even harder: deeper TME modeling, sub-100ms screens, and faster pilot rollouts for oncology teams. Momentum building as we raise $2M to put LURA in drug discovery pipelines worldwide.

//02 Differentiator

//02 Differentiator

Lura's Edge

Lura's Edge

001

HPC Native

500+ full 3D tumor simulations per second; GPU-accelerated neural architecture; Cloud-scale parallel execution.

002

Spatial Physics

Biomechanical tumor microenvironment modeling; Spatial drug penetration dynamics; Cell-level resolution physics.

003

Causal Mechanistic Intelligence

Explainable predictions that reveal active pathways, resistance drivers, and tumor-context effects — not just a score.

004

Accelerated Decision-Making

10× faster prioritization of promising candidates with mechanistic confidence — fewer dead-end experiments, lower risk entering trials.

001

HPC Native

500+ full 3D tumor simulations per second; GPU-accelerated neural architecture; Cloud-scale parallel execution.

002

Spatial Physics

Biomechanical tumor microenvironment modeling; Spatial drug penetration dynamics; Cell-level resolution physics.

003

Causal Mechanistic Intelligence

Explainable predictions that reveal active pathways, resistance drivers, and tumor-context effects — not just a score.

004

Accelerated Decision-Making

10× faster prioritization of promising candidates with mechanistic confidence — fewer dead-end experiments, lower risk entering trials.

//03 Our Metrics

//03 Our Metrics

//03 Our Metrics

Platform Performance

LURA accelerates and de-risks cancer drug discovery and relational mapping with validated, mechanistic simulation.

0K+

0K+

Drug-Cell Line Predictions Validated

0K+

0K+

Drug-Cell Line Predictions Validated

0.0x

0.0x

Faster Candidate Prioritization

0.0x

0.0x

Faster Candidate Prioritization

0%

0%

Correlation in Blind Validation

0%

0%

Correlation in Blind Validation

0ms

0ms

full portfolio screen (1,447 drugs)

0ms

0ms

Full portfolio screen

Why These Numbers Matter

Traditional oncology discovery wastes billions on candidates that fail due to unmodeled 3D barriers and mechanisms. LURA's physics + AI approach cuts through that — delivering 10–20× faster insights, validated accuracy, and sub-second responses so teams focus on winners.

Our Team

OUR TEAM

OUR TEAM

Team member

Aanu Oshakuade

Co-Founder/CEO | Computer Engineering | AI/ML

Team member

Elisha Sannousi

Co-Founder | Clinical & Translational Engineer (M.S. Translational Medicine, Bioengineering)

Team member

Samuel Tandeka

Co-Founder | Engineering Management & Business Development (M.S. Engineering Management) (B.S. Electrical Eng.)

//00 FAQ

LURA Explained

The core questions partners and researchers ask about our 3D neural engine — and how it accelerates cancer drug discovery.

Learn More

Learn More

What is LURA?

LURA is a production-scale 3D physics engine for cancer drug discovery. It builds full, configurable virtual tumor microenvironments and runs millions of virtual experiments to show what actually works — and why — before any wet-lab spend.

Does LURA handle different cancer stages and metastasis?

Yes. Stage I and Stage IV of the same tumor type have completely different parameters — hypoxia, EMT, immune evasion, glucose dependency, etc. Metastatic behavior and TME composition are modeled as distinct, differentiable states so you see exactly how progression changes drug response.

What can I actually test with LURA?

Single agents and full dose-response curves Drug combinations and sequencing Timing & scheduling (e.g., 3 days on, 4 days off) Custom mutations, TME compositions, hypoxia levels, or patient-derived profiles Mechanistic “why it failed” explanations and pathway impacts Rapid repurposing screens across multiple indications

Is the system validated on real cancers and drugs?

Yes — built and tested against hundreds of thousands of historical drug-tumor response measurements across diverse solid tumors. It reproduces known clinical patterns and explains documented failures with clear, physics-based reasoning

How accurate and fast is LURA?

LURA achieves 80–88% correlation with real biological outcomes while delivering hundreds of full 3D tumor simulations per second. A 1,000-compound screen on one tumor model finishes in under 2 minutes; millions of experiments run in hours.

How easy is it for wet-lab teams to use?

Extremely. The V5 dashboard requires no coding. Select or upload your tumor context, choose compounds, run simulations, and get interactive 3D views, dose curves, and plain-English mechanistic summaries. Results are reproducible and ready to share with your team.